Pulmonary arteriovenous - Malformations screening procedures and pulmonaryangiography in patients with hereditary hemorrhagic telangiectasia

Citation
Ad. Kjeldsen et al., Pulmonary arteriovenous - Malformations screening procedures and pulmonaryangiography in patients with hereditary hemorrhagic telangiectasia, CHEST, 116(2), 1999, pp. 432-439
Citations number
39
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CHEST
ISSN journal
00123692 → ACNP
Volume
116
Issue
2
Year of publication
1999
Pages
432 - 439
Database
ISI
SICI code
0012-3692(199908)116:2<432:PA-MSP>2.0.ZU;2-G
Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inh erited disease with a high prevalence of pulmonary arteriovenous malformati ons (PAVMs). The first symptom of HHT may be stroke or fatal hemoptysis ass ociated with the presence of PAVM. Objective: To evaluate different screening methods applied for the identifi cation of PAVMs. Setting: Odense University Hospital. Subjects: HHT patients with positive findings on contrast echocardiography (CE) who participated in a screening investigation and underwent pulmonary angiography (PA), Methods: Different screening methods were evaluated against the results of PA, In a group of patients with positive findings on CE, we compared result s of PA with the following: severity of dyspnea; results of pulse oximetry arterial oxygen saturation (Sao(2)) supine and upright; supine Pao, in room air and while breathing 100% oxygen; size of arteriovenous shunt in supine position; chest radiograph; and intensity of contrast at CE, Results: PA was performed in 25 HHT patients with positive findings on CE, 15 of whom had PAVM. Embolization therapy was recommended in 12 patients, a nd 3 patients had small PAVMs not accessible for therapy, In 10 patients, P AVM could not be demonstrated at PA. The sensitivity and specificity calcul ated for the screening procedures are as follows: 53% and 90%, respectively , for Sao,; 60% and 100%, respectively, for chest radiograph; 73% and 80%, respectively, for Pao, in room air; 100% and 40%, respectively, for Pao, br eathing 100% oxygen; and 64% and 80%, respectively, for shunt measurement. Conclusion: Initial screening with CE followed by measurement of Pao, while breathing 100% oxygen seemed to be the best screening procedure for identi fication of patients with PAVM. Screening with chest radiograph and pulse o ximetry was shown to be insufficient.